Auro Laboratories Limited (BOM:530233)
India flag India · Delayed Price · Currency is INR
288.00
-3.80 (-1.30%)
At close: Mar 9, 2026

Auro Laboratories Company Description

Auro Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs), intermediates, and generic formulations in India.

It offers antihistamine; muscle relaxant; diuretic; iron deficiency; anti-diabetic, including Metformin HCL; anti-fungal, ulcer, malaria, and inflammatory; iodine supplement; analgesics; antacids; potassium and sodium iodide; and microcrystalline cellulose.

The company also provides specialty chemicals comprising guanidine nitrate; dimethyl amine HCl; 2-ethoxy benzoic acid; and 3,4,5 - trimethoxy benzoic acid.

In addition, it offers intermediates consisting of glibenclamde sulphonamide for use in API glibenclamide; cis-bramo benzoate and cls-tosylate that are used in API Ketoconazol; 3,4,5 - trimethoxy benzoic acid; 2-ethoxy benzoic acid for use in API sildenafil citrate; and 5-bromo phthalide that is used in API citalopram.

It also exports products to Egypt, Germany, Malaysia, Singapore, South Africa, Brazil, Spain, and the United Kingdom.

The company was incorporated in 1989 and is based in Mumbai, India.

Auro Laboratories Limited
Country India
Founded 1989
Industry Medicinal Chemicals and Botanical Products
Employees 72
CEO Sharat Deorah

Contact Details

Address:
314, T.V. Industrial Estate
Mumbai, Maharashtra 400030
India
Phone 91 22 6663 5456
Website aurolabs.com

Stock Details

Ticker Symbol 530233
Exchange Bombay Stock Exchange
Fiscal Year April - March
Reporting Currency INR
SIC Code 2833

Key Executives

Name Position
Sharat Deorah Chief Executive Officer
Kuntal Pancholi Chief Financial Officer